Instituto Grifols S.A.
PolandAll medications by this manufacturer
-
Albutein 200 g/l
Form: solution for infusion
Active substance Dosage Human albumin solution 200 g/1 l ATC: B05AA01
-
Albutein 50 g/l
Form: solution for infusion
Active substance Dosage Human albumin solution 50 g/1 l ATC: B05AA01
-
Anbinex
Form: powder and solvent for preparation of infusion solution
Active substance Dosage Human antithrombin III 500 j.m. ATC: B01AB02
-
Anbinex
Form: powder and solvent for preparation of infusion solution
Active substance Dosage Human antithrombin III 1000 j.m. ATC: B01AB02
-
Fanhdi
Form: powder and solvent for solution for injection and infusion
Active substance Dosage human von Willebrand factor 300 j.m. human blood coagulation factor VIII 250 j.m. ATC: B02BD06
-
Fanhdi
Form: powder and solvent for solution for injection and infusion
Active substance Dosage Human blood coagulation factor VIII 1000 j.m. Human von Willebrand factor 1200 j.m. ATC: B02BD06
-
Fanhdı
Form: powder and solvent for solution for injection and infusion
Active substance Dosage Human blood coagulation factor VIII 500 j.m. Human von Willebrand factor 600 j.m. ATC: B02BD06
-
Gamunex 10%
Form: solution for infusion
Active substance Dosage Human normal immunoglobulin 100 mg/ml ATC: J06BA02
-
Human albumin grifols 20%
Form: solution for infusion
Active substance Dosage Human albumin 200 g ATC: B05AA01
-
Igantet 250
Form: solution for injection
Active substance Dosage protein 160 mg ATC: J06BB02
-
Igantet 500
Form: solution for injection
ATC: J06BB02
-
Prolastin
Form: powder and solvent for preparation of infusion solution
Active substance Dosage human alpha-1-proteinase inhibitor 4000 mg ATC: B02AB02
-
Prolastin
Form: powder and solvent for preparation of infusion solution
Active substance Dosage human alpha-1-proteinase inhibitor 5000 mg ATC: B02AB02
-
Xembify
Form: solution for injection, subcutaneous
Active substance Dosage Normal human immunoglobulin (SCIg) 18 to 22 % ATC: J06BA01